Kangmei Pharma | 600518 - Zinsaufwendungen Für Schuld

Aktienkurs
1.76
Täglich Wechseln
0.02 1.15%
Monatlich
-7.37%
Jährlich
-17.37%
Q1 Prognose
1.70




Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 4.83M 359.32M 2025-12
Alaunos Therapeutics USD 1.07M 215K 2023-06
Avita Medical AUD 1.25M 100K 2025-06
Cspc Pharmaceutical CNY 10.19M 4.73M 2025-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Genomma Lab Internacional MXN 190.68M 972K 2025-12
Hypermarcas BRL 36.54M 3.75M 2025-12
Ionis Pharmaceuticals USD 18M 0 2025-12
IQVIA Holdings USD 193M 4M 2025-12
Jiangsu Hengrui CNY 254.59M 253.85M 2025-09
Kangmei Pharma CNY 1.82M 150K 2025-09
Moderna USD 12.14B 12.13B 2025-09
Organon & Co USD 128M 3M 2025-09
Revvity USD 23.51M 742K 2025-12
Sh Fosun Pharma CNY 321.25M 2M 2025-09
Tectonic Therapeutic USD 12K 276.99M 2025-12
Viatris USD 119.6M 0 2025-12
Wuxi Apptec CNY 103.05M 37.29M 2025-06
Xeris Pharmaceuticals USD 7.15M 115K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06